373 related articles for article (PubMed ID: 24945377)
1. Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies.
Blodörn K; Hägglund S; Fix J; Dubuquoy C; Makabi-Panzu B; Thom M; Karlsson P; Roque JL; Karlstam E; Pringle J; Eléouët JF; Riffault S; Taylor G; Valarcher JF
PLoS One; 2014; 9(6):e100392. PubMed ID: 24945377
[TBL] [Abstract][Full Text] [Related]
2. A new subunit vaccine based on nucleoprotein nanoparticles confers partial clinical and virological protection in calves against bovine respiratory syncytial virus.
Riffault S; Meyer G; Deplanche M; Dubuquoy C; Durand G; Soulestin M; Castagné N; Bernard J; Bernardet P; Dubosclard V; Bernex F; Petit-Camurdan A; Deville S; Schwartz-Cornil I; Eléouët JF
Vaccine; 2010 May; 28(21):3722-34. PubMed ID: 20307593
[TBL] [Abstract][Full Text] [Related]
3. Characterization of an experimental vaccine for bovine respiratory syncytial virus.
Hägglund S; Hu K; Blodörn K; Makabi-Panzu B; Gaillard AL; Ellencrona K; Chevret D; Hellman L; Bengtsson KL; Riffault S; Taylor G; Valarcher JF; Eléouët JF
Clin Vaccine Immunol; 2014 Jul; 21(7):997-1004. PubMed ID: 24828093
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge.
Antonis AF; van der Most RG; Suezer Y; Stockhofe-Zurwieden N; Daus F; Sutter G; Schrijver RS
Vaccine; 2007 Jun; 25(25):4818-27. PubMed ID: 17499893
[TBL] [Abstract][Full Text] [Related]
5. Bovine model of respiratory syncytial virus infection.
Taylor G
Curr Top Microbiol Immunol; 2013; 372():327-45. PubMed ID: 24362697
[TBL] [Abstract][Full Text] [Related]
6. Bovine respiratory syncytial virus ISCOMs-Immunity, protection and safety in young conventional calves.
Hägglund S; Hu K; Vargmar K; Poré L; Olofson AS; Blodörn K; Anderson J; Ahooghalandari P; Pringle J; Taylor G; Valarcher JF
Vaccine; 2011 Nov; 29(47):8719-30. PubMed ID: 21864616
[TBL] [Abstract][Full Text] [Related]
7. Recombinant vaccinia viruses expressing the F, G or N, but not the M2, protein of bovine respiratory syncytial virus (BRSV) induce resistance to BRSV challenge in the calf and protect against the development of pneumonic lesions.
Taylor G; Thomas LH; Furze JM; Cook RS; Wyld SG; Lerch R; Hardy R; Wertz GW
J Gen Virol; 1997 Dec; 78 ( Pt 12)():3195-206. PubMed ID: 9400970
[TBL] [Abstract][Full Text] [Related]
8. A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus.
Díaz FE; Guerra-Maupome M; McDonald PO; Rivera-Pérez D; Kalergis AM; McGill JL
Front Immunol; 2021; 12():664212. PubMed ID: 33981309
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections.
Taylor G; Thom M; Capone S; Pierantoni A; Guzman E; Herbert R; Scarselli E; Napolitano F; Giuliani A; Folgori A; Colloca S; Cortese R; Nicosia A; Vitelli A
Sci Transl Med; 2015 Aug; 7(300):300ra127. PubMed ID: 26268314
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a saponin-adjuvanted inactivated respiratory syncytial virus vaccine in calves.
Ellis JA; West KH; Waldner C; Rhodes C
Can Vet J; 2005 Feb; 46(2):155-62. PubMed ID: 15825518
[TBL] [Abstract][Full Text] [Related]
11. Protection against bovine respiratory syncytial virus in calves vaccinated with adjuvanted modified live vaccine administered in the face of maternal antibody.
Kolb EA; Buterbaugh RE; Rinehart CL; Ensley D; Perry GA; Abdelsalam KW; Chase CCL
Vaccine; 2020 Jan; 38(2):298-308. PubMed ID: 31668818
[TBL] [Abstract][Full Text] [Related]
12. Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves.
Taylor G; Wyld S; Valarcher JF; Guzman E; Thom M; Widdison S; Buchholz UJ
J Gen Virol; 2014 Jun; 95(Pt 6):1244-1254. PubMed ID: 24700100
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf.
McGill JL; Kelly SM; Kumar P; Speckhart S; Haughney SL; Henningson J; Narasimhan B; Sacco RE
Sci Rep; 2018 Feb; 8(1):3021. PubMed ID: 29445124
[TBL] [Abstract][Full Text] [Related]
14. Response of calves to challenge exposure with virulent bovine respiratory syncytial virus following intranasal administration of vaccines formulated for parenteral administration.
Ellis J; Gow S; West K; Waldner C; Rhodes C; Mutwiri G; Rosenberg H
J Am Vet Med Assoc; 2007 Jan; 230(2):233-43. PubMed ID: 17223757
[TBL] [Abstract][Full Text] [Related]
15. Vaccine-induced immunopathology during bovine respiratory syncytial virus infection: exploring the parameters of pathogenesis.
Antonis AF; Schrijver RS; Daus F; Steverink PJ; Stockhofe N; Hensen EJ; Langedijk JP; van der Most RG
J Virol; 2003 Nov; 77(22):12067-73. PubMed ID: 14581543
[TBL] [Abstract][Full Text] [Related]
16. Formulation with CpG oligodeoxynucleotides increases cellular immunity and protection induced by vaccination of calves with formalin-inactivated bovine respiratory syncytial virus.
Mapletoft JW; Oumouna M; Townsend HG; Gomis S; Babiuk LA; van Drunen Littel-van den Hurk S
Virology; 2006 Sep; 353(2):316-23. PubMed ID: 16828832
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of an inactivated respiratory syncytial virus vaccine in calves.
Ellis J; West K; Konoby C; Leard T; Gallo G; Conlon J; Fitzgerald N
J Am Vet Med Assoc; 2001 Jun; 218(12):1973-80. PubMed ID: 11417745
[TBL] [Abstract][Full Text] [Related]
18. DNA vaccination against respiratory syncytial virus in young calves.
Taylor G; Bruce C; Barbet AF; Wyld SG; Thomas LH
Vaccine; 2005 Jan; 23(10):1242-50. PubMed ID: 15652666
[TBL] [Abstract][Full Text] [Related]
19. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
[TBL] [Abstract][Full Text] [Related]
20. Mucosal immunization with live recombinant bovine respiratory syncytial virus (BRSV) and recombinant BRSV lacking the envelope glycoprotein G protects against challenge with wild-type BRSV.
Schmidt U; Beyer J; Polster U; Gershwin LJ; Buchholz UJ
J Virol; 2002 Dec; 76(23):12355-9. PubMed ID: 12414977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
